Real-time enrollment status for this netherton syndrome clinical trial
Current Status
Active, Not Recruiting
Checked: April 17, 2026 at 3:43 AM UTC
| NCT Number | NCT05521438 |
| Recruiting Status | Active, Not Recruiting |
| Condition | Netherton Syndrome |
| Phase | Clinical Trial |
| Target Enrollment | 30 participants |
| Active Locations | 5 sites in the US |
| Sponsor | Quoin Pharmaceuticals |
| Last Updated on CT.gov | March 16, 2026 (Mar 16, 2026) |
As of April 17, 2026: Clinical trial NCT05521438 is currently active_not_recruiting participants. This clinical trial study for netherton syndrome is not currently accepting new participants at 5 locations across the United States. The study is sponsored by Quoin Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT05521438 is currently active_not_recruiting. The study may resume recruiting in the future.
This trial is recruiting at 5 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05521438 was last updated Mar 16, 2026 (March 16, 2026). HelloStudys verifies this status automatically.